Treatment of Hypercholesterolemia:
Comparison of younger versus Older Patients Using Wax-Matrix Sustained-Release Niacin
Treatment of Hypercholesterolemia:
Comparison of younger versus Older Patients Using Wax-Matrix Sustained-Release Niacin
A Randomized, Controlled Trial of Wax-Matrix Sustained -Release Niacin in Hypercholesterolemia
Structure of Chemical Compounds, Methods of Analysis and Process Control
Quantitive Determination of Enduracin in Blood Stream
Womens Health Update
Two Important Interventions for Women and Cardiovascular disease
Dissolution Profiles of Non-Prescription Niacin & Niaspan
Kinetics of Enduracin
Wax-Matrix ER Niacin Tolerability
In the December 27 e-Alert, we wrote to you about a new way to assess your risk of heart disease. It’s the ratio between apolipoprotein B (apo B) and apolipoprotein A-1 (apo A-1), and studies have shown it can be even more meaningful than the HDL/LDL ratio. In fact, in the study I wrote about last month, men with the highest levels of apo B and the lowest levels of apo A-1 were nearly FOUR TIMES as likely to have a fatal heart attack than those with opposite values. (You can view this e-Alert on our website, www.hsibaltimore.com, on the “Current e-Alerts” page.)
Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans